New website will be launched in the spring
  • Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Development Partners
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
  • Contact
  • en
  • sv
  • Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Development Partners
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
  • Contact
  • en
  • sv

Archives

Home / Author: Erika Medin
  0
By Erika Medin
In News
Posted 24 February 2021

GMP manufacturing of Apta-1 according to plan

Aptahem AB (publ) announce today that the company has signed an agreement with their collaboration partner LGC Group to initiate the GMP (Good Manufacturing Practice) manufacturing of Apta-1. [...]

READ MORE
  0
By Erika Medin
In News
Posted 8 February 2021

Aptahem receives patent approval in India for patent family 1

Aptahem AB (publ) announce today that the company has received patent approval in India for patent family 1, with patent application number 6250/DELNP/2010. The patent, with the patent number [...]

READ MORE
  0
By Erika Medin
In News
Posted 22 December 2020

BioStock article: Aptahem’s wish list for next year’s Christmas

BioStock published an article on 22 December 2020 about Aptahem, which can be read in full below. Aptahem, which is developing an emergency medicine for the treatment of sepsis, carried out an [...]

READ MORE
  0
By Erika Medin
In News
Posted 8 December 2020

BioStock article: Aptahem looks ahead with optimism

BioStock published an article on 8 December 2020 about Aptahem, which can be read in full below. Aptahem, whose primary drug candidate Apta-1 is being developed as an emergency treatment [...]

READ MORE
  0
By Erika Medin
In News
Posted 26 November 2020

BioStock article: Aptahem approaching milestone via oversubscribed rights issue

BioStock published an article on 26 November 2020 about Aptahem, which can be read in full below. Biotechnology company Aptahem, that develops its drug candidate Apta-1 for the treatment of [...]

READ MORE
  0
By Erika Medin
In News
Posted 21 October 2020

Aptahem enters collaboration agreement with Granzer Regulatory Consulting and Services to prepare for clinical stage

Aptahem AB (publ), announce today that the company enters a collaboration agreement with the German company Granzer Regulatory Consulting and Services to prepare for applications to the European [...]

READ MORE
  0
By Erika Medin
In News
Posted 16 October 2020

BioStock article: Aptahem’s founder is back – now as Chairman of the Board

BioStock published an article on 15 October 2020 about Aptahem, which can be read in full below. On September 25, Bert Junno was elected Chairman of the Board of the biotech company Aptahem. As a [...]

READ MORE
  0
By Erika Medin
In News
Posted 3 September 2020

The Chairman of the Board of Directors at Aptahem has announced his resignation

Aptahem AB (publ), announce today that the Chairman of the Board of Directors, Kjell G Stenberg, has requested his own resignation from the Board. Due to this, the Board of Directors will call [...]

READ MORE
  0
By Erika Medin
In News
Posted 10 August 2020

The first larger scale production campaign of Aptahem’s lead candidate Apta-1 is now ready to start

Aptahem AB, a leading developer of aptamer-based drugs, announced today that the company is now starting large-scale manufacturing after LGC Bioresearch Technologies Inc. (LGC) completed the [...]

READ MORE
  0
By Erika Medin
In News
Posted 10 July 2020

BioStock article: Aptahem comments on the new Covid-19 project

BioStock published an article on 10 July 2020 about Aptahem, which can be read in full below. Last night, Malmö-based Aptahem announced that they have entered a preclinical collaboration with the [...]

READ MORE
1 2 3 4 5 6
page 1 of 6
Contact



Norra Vallgatan 58, 4 TR
211 22 Malmö
Sweden
E-mail: info@aptahem.com

Aptahem is supporting Sepsisfonden & Global Sepsis Alliance
To all salesmen:

We kindly decline all direct contact with salesmen of different types of products and services.

Copyright All Rights Reserved © 2016

Start typing and press Enter to search